Temporal change of risk factors in hospital-acquired Clostridioides difficile infection using time-trend analysis.

作者: Jiyoun Song , Bevin Cohen , Philip Zachariah , Jianfang Liu , Elaine L. Larson

DOI: 10.1017/ICE.2020.206

关键词:

摘要: OBJECTIVE Given recent changes in the epidemiology of Clostridioides difficile infection (CDI) and prevention efforts, we investigated temporal over a period 11 years (2006-2016) incidence risk factors for CDI. DESIGN Retrospective matched case-control study. SETTING/PATIENTS Pediatric adult inpatients (n = 694,849) discharged from 3 hospitals (tertiary quaternary care, community, pediatric) large, academic health center New York City. METHODS Risk were identified cases controls by length stay at ratio 1:4. A Cochran-Armitage or Mann-Kendall test was used to investigate trends factors. RESULTS Of 694,849 inpatients, 6,038 (0.87%) had CDI: 44% these hospital acquired (HA-CDI) 56% community (CA-CDI). We observed downward HA-CDI (-0.03% per year) upward CA-CDI (+0.04% year). Over time, antibiotics administered more patients (+3% year); use high-risk declined (-1.2% antibiotic duration increased with (+4.4% Fewer proton-pump inhibitors histamine-2 blockers (-3.8% +7.3% year, respectively; all Ptrend <.05). CONCLUSIONS Although decreased simultaneously increased. Continued efforts assure judicious inpatient settings is clearly vital. Measuring actual level exposure an (incidence density) should be ongoing surveillance assessment.

参考文章(35)
EJ Kuijper, B Coignard, JS Brazier, C Suetens, D Drudy, C Wiuff, H Pituch, P Reichert, F Schneider, AF Widmer, K EP Olsen, F Allerberger, DW Notermans, F Barbut, Michel Delmée, M Wilcox, A Pearson, B Patel, DJ Brown, R Frei, T Akerlund, IR Poxton, Peet Tüll, None, Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe. Eurosurveillance. ,vol. 12, pp. 1- 2 ,(2007) , 10.2807/ESM.12.06.00714-EN
Kristin E. Burke, J. Thomas Lamont, Clostridium difficile infection: a worldwide disease. Gut and Liver. ,vol. 8, pp. 1- 6 ,(2014) , 10.5009/GNL.2014.8.1.1
Mary E. Charlson, Peter Pompei, Kathy L. Ales, C.Ronald MacKenzie, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation☆ Journal of Chronic Diseases. ,vol. 40, pp. 373- 383 ,(1987) , 10.1016/0021-9681(87)90171-8
Roger Baxter, G. Thomas Ray, Bruce H. Fireman, Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients. Infection Control and Hospital Epidemiology. ,vol. 29, pp. 44- 50 ,(2008) , 10.1086/524320
G. S. Bobulsky, W. N. Al-Nassir, M. M. Riggs, A. K. Sethi, C. J. Donskey, Clostridium difficile skin contamination in patients with C. difficile-associated disease. Clinical Infectious Diseases. ,vol. 46, pp. 447- 450 ,(2008) , 10.1086/525267
Yanal M. Murad, Justo Perez, Reza Nokhbeh, Gustavo Ybazeta, Brenda Dewar, Sebastien Lefebvre, Francisco Diaz-Mitoma, Impact of polymerase chain reaction testing on Clostridium difficile infection rates in an acute health care facility American Journal of Infection Control. ,vol. 43, pp. 383- 386 ,(2015) , 10.1016/J.AJIC.2014.12.021
N. Berry, B. Sewell, S. Jafri, C. Puli, S. Vagia, A.M. Lewis, D. Davies, E. Rees, C.L. Ch'ng, Real-time polymerase chain reaction correlates well with clinical diagnosis of Clostridium difficile infection Journal of Hospital Infection. ,vol. 87, pp. 109- 114 ,(2014) , 10.1016/J.JHIN.2014.03.005
Emily G. McDonald, Jonathon Milligan, Charles Frenette, Todd C. Lee, Continuous Proton Pump Inhibitor Therapy and the Associated Risk of RecurrentClostridium difficileInfection JAMA Internal Medicine. ,vol. 175, pp. 784- 791 ,(2015) , 10.1001/JAMAINTERNMED.2015.42
Kevin A. Brown, David N. Fisman, Rahim Moineddin, Nick Daneman, The Magnitude and Duration of Clostridium difficile Infection Risk Associated with Antibiotic Therapy: A Hospital Cohort Study PLoS ONE. ,vol. 9, pp. e105454- ,(2014) , 10.1371/JOURNAL.PONE.0105454
David J. Weber, Deverick Anderson, William A. Rutala, The role of the surface environment in healthcare-associated infections. Current Opinion in Infectious Diseases. ,vol. 26, pp. 338- 344 ,(2013) , 10.1097/QCO.0B013E3283630F04